GlaxoSmithKline
GSK
#194
Rank
$88.06 B
Marketcap
$43.01
Share price
-0.23%
Change (1 day)
15.03%
Change (1 year)

GlaxoSmithKline (GSK) - Cash on Hand

Cash on Hand as of June 2024 : $3.77 B

According to GlaxoSmithKline's latest financial reports the company has $3.77 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

GlaxoSmithKline - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$6.35 B-31.52%
2022-12-31$9.28 B65.96%
2021-12-31$5.59 B-33.56%
2020-12-31$8.42 B38.4%
2019-12-31$6.08 B20.51%
2018-12-31$5.05 B-4.46%
2017-12-31$5.28 B-14.08%
2016-12-31$6.15 B-29.77%
2015-12-31$8.75 B27.69%
2014-12-31$6.86 B-25.82%
2013-12-31$9.24 B34.1%
2012-12-31$6.89 B-24.77%
2011-12-31$9.16 B-4.53%
2010-12-31$9.60 B-13.83%
2009-12-31$11.14 B12.49%
2008-12-31$9.90 B9.35%
2007-12-31$9.05 B52.18%
2006-12-31$5.95 B-34.03%
2005-12-31$9.02 B18.28%
2004-12-31$7.62 B24.67%
2003-12-31$6.11 B54.58%
2002-12-31$3.95 B17.62%
2001-12-31$3.36 B-37.22%
2000-12-31$5.36 B68.76%
1999-12-31$3.17 B1.35%
1998-12-31$3.13 B14.81%
1997-12-31$2.73 B26.34%
1996-12-31$2.16 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$7.07 B 87.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
$7.10 B 88.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.35 B 200.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.43 B 123.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$7.28 B 93.00%๐Ÿ‡ซ๐Ÿ‡ท France
$2.25 B-40.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$0.73 B-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA